# FDA Inspection 1034171 - Biomat USA Inc - November 02, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/a6bcbdb8-52e9-415e-b3b4-60622c053a07
Source feed: FDA_Inspections

> FDA Inspection 1034171 for Biomat USA Inc on November 02, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1034171
- Company Name: Biomat USA Inc
- Inspection Date: 2017-11-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 920794 - 2015-04-03](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/50b70194-cecf-4d3a-b77b-759e9dc08d48)
- [FDA Inspection 756114 - 2011-11-18](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/a6ee2f88-ca71-4473-920f-5d640b2096bb)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/681c4c62-ae65-4d88-ad58-f3344301caaa

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d